ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted antibody-based anticancer therapeutics, today provided information on the clinical data presentations related to the Company to be made at the upcoming American Society of Hematology (ASH) annual meeting to be held December 7-10, 2013 in New Orleans, LA.
Help employers find you! Check out all the jobs and post your resume.
